Please Login to read the full article.
Clinica
St Jude: CE mark for Genesis migraine therapy the "starting point" of new neurostim opportunity
08 September 2011
Tina Tan
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
- CardioMEMS's cardiac monitor reduces hospitalisations in heart failure patients
- Familial cholesterol tests from Gen-Probe, Progenika fall short of NICE expectations
- St Jude picks up Medtronic's GPO slack with new contract
Other Informa News
